Register to chat with like-minded investors on our interactive forums.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 Next >>

Date	Time	Source	Headline	Symbol	Company
05/30/2019	8:00AM	PR Newswire (Canada)	MAVIRET(MC) d'AbbVie maintenant inscrit sur la liste des médicaments du Nouveau-Brunswick	NYSE:ABBV	AbbVie Inc
05/30/2019	8:00AM	PR Newswire (Canada)	AbbVie's MAVIRET™ now listed in New Brunswick	NYSE:ABBV	AbbVie Inc
05/29/2019	2:30PM	Dow Jones News	Johnson & Johnson Weighs on Pharmaceutical ETFs	NYSE:ABBV	AbbVie Inc
05/23/2019	9:00AM	PR Newswire (Canada)	AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for VENCLEXTA®, a treatment for chronic lym...	NYSE:ABBV	AbbVie Inc
05/23/2019	9:00AM	PR Newswire (Canada)	AbbVie conclut une entente avec l'Alliance pancanadienne pharmaceutique (APP) concernant VENCLEXTA®, un traitement de la leu...	NYSE:ABBV	AbbVie Inc
05/21/2019	8:00AM	PR Newswire (Canada)	AbbVie Launches ORILISSA™ (elagolix) 200 mg BID Dose for the Treatment of Moderate to Severe Pain Associated with Endometri...	NYSE:ABBV	AbbVie Inc
05/21/2019	8:00AM	PR Newswire (Canada)	AbbVie met sur le marché la dose d'ORILISSA(MC) (élagolix) à 200 mg deux fois par jour pour le traitement des douleurs mod...	NYSE:ABBV	AbbVie Inc
05/17/2019	9:31AM	Dow Jones News	AbbVie Glioblastoma Drug Misses Primary Endpoint	NYSE:ABBV	AbbVie Inc
05/17/2019	8:45AM	PR Newswire (US)	AbbVie Provides Update on Depatuxizumab Mafodotin (Depatux-M), an Investigational Medicine for Newly Diagnosed Glioblastoma, ...	NYSE:ABBV	AbbVie Inc
05/15/2019	3:30PM	Dow Jones News	Genentech Says FDA Approves Venclexta Plus Gazyva for Chronic Lymphocytic Leukemia	NYSE:ABBV	AbbVie Inc
05/15/2019	2:19PM	PR Newswire (US)	AbbVie Announces US FDA Approval of VENCLEXTA® (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untrea...	NYSE:ABBV	AbbVie Inc
05/15/2019	3:02AM	Dow Jones News	Drugmakers Settle U.S. Patent Dispute Over Clone of Humira -- WSJ	NYSE:ABBV	AbbVie Inc
05/14/2019	12:16PM	Dow Jones News	AbbVie, Boehringer Ingelheim in U.S. Settlement on Humira Biosimilar -- Update	NYSE:ABBV	AbbVie Inc
05/14/2019	10:13AM	Business Wire	MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System	NYSE:ABBV	AbbVie Inc
05/14/2019	9:53AM	Dow Jones News	AbbVie, Boehringer Ingelheim in U.S. Settlement on Humira Biosimilar	NYSE:ABBV	AbbVie Inc
05/14/2019	8:34AM	PR Newswire (US)	AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim	NYSE:ABBV	AbbVie Inc
05/14/2019	8:00AM	PR Newswire (US)	AbbVie to Present at the UBS Global Healthcare Conference	NYSE:ABBV	AbbVie Inc
05/08/2019	5:45PM	Dow Jones News	Drug Prices to Be Disclosed in TV Ads Soon -- Update	NYSE:ABBV	AbbVie Inc
05/08/2019	1:38PM	Dow Jones News	Drug Prices to Be Disclosed in TV Ads Soon	NYSE:ABBV	AbbVie Inc
05/07/2019	4:57PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:57PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:57PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:54PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:54PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:51PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	4:50PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/07/2019	8:00AM	PR Newswire (US)	AbbVie to Present at the Bank of America Merrill Lynch Healthcare Conference	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 Next >>

Ethema Health (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

Lightwave Logic

Kraig Biocraft Laborator... (QB)

Rennova Health (PK)

RespireRx Pharmaceuticals (PK)

Elite Pharmaceuticals (QB)

Net Savings Link (PK)

Delayed Upgrade Clock